An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis
暂无分享,去创建一个
[1] A. Leonard,et al. Mutagenicity, carcinogenicity and teratogenicity of zinc. , 1986, Mutation research.
[2] P. V. Ioannou,et al. Selenium status of cancer patients in Greece. , 1990, The Science of the total environment.
[3] T. Mcgarrity,et al. Selenium and difluoromethylornithine additively inhibit DMH-induced distal colon tumor formation in rats fed a fiber-free diet. , 1993, Carcinogenesis.
[4] J. Schenker,et al. Copper and Zinc levels in normal and malignant tissues , 1983, Cancer.
[5] A. N. Garg,et al. Radiochemical neutron activation analysis of Fe, Co, Zn, Sb and Se in biomedical and environmental samples. , 1993, The Science of the total environment.
[6] F. Burbank,et al. CORRELATIONS BETWEEN CARCINOGENIC TRACE METALS IN WATER SUPPLIES AND CANCER MORTALITY , 1972, Annals of the New York Academy of Sciences.
[7] M. Vuillaume. Reduced oxygen species, mutation, induction and cancer initiation. , 1987, Mutation research.
[8] T Takeuchi,et al. FETAL MINAMATA DISEASE: A NEUROPATHOLOGICAL STUDY OF TWO CASES OF INTRAUTERINE INTOXICATION BY A METHYL MERCURY COMPOUND , 1965, Journal of neuropathology and experimental neurology.
[9] Eleanor Berman,et al. Toxic metals and their analysis , 1980 .
[10] E. Merian. Metals and their compounds , 2004 .
[11] E. Underwood. Trace Elements in Human and Animal Nutrition , 1956, Agronomy Journal.
[12] D. Bleyl,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .
[13] A. Lipcsey,et al. Application of neutron activation analysis and spectrophotometry for the determination of copper level in sera and cerebrospinal fluids of schizophrenic patients , 1985 .
[14] J. Milner,et al. Inhibition of human breast cancer cells by selenium. , 1984, Cancer letters.
[15] J. Góes,et al. Biochemical studies on copper, copper oxidase, magnesium, sulfur, calcium and phosphorus in cancer of the breast , 1965 .
[16] J. Hamilton,et al. Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression. , 1989, The Science of the total environment.
[17] W. D. Ehmann,et al. Brain manganese concentrations in human aging and Alzheimer's disease. , 1984, Neurotoxicology.
[18] J. D. de Goeij,et al. Selenium levels in blood and plasma, and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil. , 1983, Cancer letters.
[19] G. Canellos,et al. Serum ferritin concentration in untreated Hodgkin's disease. , 1976, British Journal of Cancer.
[20] P. Chakravarty,et al. Zinc in human malignancies. , 1986, Neoplasma.
[21] A. N. Garg,et al. Minor and trace elemental contents of cancerous breast tissue measured by instrumental and radiochemical neutron activation analysis , 1990, Biological Trace Element Research.
[22] W. Delaney,et al. Trace-metal analysis of cancerous and noncancerous human tissues. , 1971, Journal of the National Cancer Institute.
[23] H. Bowen. Chapter 1 Trace Elements in Biological Samples , 1988 .
[24] L. Loeb,et al. Infidelity of DNA synthesis in vitro: screening for potential metal mutagens or carcinogens. , 1976, Science.
[25] J. Versieck,et al. Trace elements in human body fluids and tissues. , 1985, Critical reviews in clinical laboratory sciences.
[26] Scheinberg Ih. Wilson's disease. , 1981 .
[27] A. N. Garg,et al. Neutron activation analysis of geological and biological samples using short-term reactor irradiation and successive counting , 1986 .
[28] R. W. Fink,et al. Trace elements in noraml and malignant human breast tissue. , 1974, Surgery.
[29] I. El-Dosoky,et al. Elevation of glutathione, glutathione-reductase and nucleic acids in both normal tissues and tumour of breast cancer patients. , 1993, Cancer letters.
[30] H. Foster. Selenium and cancer prevention. , 1988, The Journal of nutrition.
[31] C. Grossi,et al. Treatment of early cancer of the breast (T1N0M0 and T2N0M0) on the basis of histologic characteristics. , 1981, Surgery.
[32] A. E. Rogers,et al. Diet and carcinogenesis. , 1993, Carcinogenesis.
[33] S L Rizk,et al. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. , 1984, Cancer research.
[34] G. Schrauzer,et al. Inhibition of the genesis of spontaneous mammary tumors in C3H mice: effects of selenium and of selenium-antagonistic elements and their possible role in human breast cancer. , 1976, Bioinorganic chemistry.
[35] G. Schrauzer,et al. Effects of temporary selenium supplementation on the genesis of spontaneous mammary tumors in inbred female C3H/St mice. , 1980, Carcinogenesis.
[36] G. Iyengar. Reference values for the concentrations of As, Cd, Co, Cr, Cu, Fe, I, Hg, Mn, Mo, Ni, Pb, Se, and Zn in selected human tissues and body fluids , 1987, Biological Trace Element Research.
[37] D. Jones,et al. Analysis of muscle biopsies for sodium, chlorine, potassium and phosphorus by neutron activation. , 1976, The International journal of applied radiation and isotopes.
[38] F. Rosato,et al. Serum and tissue magnesium levels in human breast carcinoma. , 1970, The Journal of surgical research.
[39] K. Heydorn. Neutron activation analysis for clinical trace element research , 1984 .
[40] P. Chappuis,et al. Antioxidants in female breast cancer patients. , 1991, Cancer investigation.
[41] M. Worwood,et al. Ferritinaemia in Leukaemia and Hodgkin's Disease , 1973, British Journal of Cancer.
[42] A. N. Garg,et al. Determination of phosphorus in biological samples by thermal neutron activation followed by β--counting , 1989 .